We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nordson's Q4 Earnings & Revenues Top Estimates, Increase Y/Y
Read MoreHide Full Article
Nordson Corporation’s (NDSN - Free Report) fourth-quarter fiscal 2024 (ended Sept. 30, 2024) adjusted earnings of $2.78 per share surpassed the Zacks Consensus Estimate of $2.59. The bottom line increased 2.6% year over year.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
Quarterly Results of NDSN
Nordson’s revenues were $744.5 million, up 4% from the year-ago fiscal quarter’s number, driven by solid momentum in the Medical and Fluid Solutions segment. Revenues beat the consensus estimate of $733 million.
Organic sales declined 3% year over year due to softness in the polymer processing and precision agriculture product lines. Acquisitions had a positive impact of 6% while foreign currency translation had a positive impact of 1%. Exiting the fiscal year, the company’s backlog totaled $580 million.
Nordson Corporation Price, Consensus and EPS Surprise
On a regional basis, revenues from the Asia Pacific region increased 7.5% year over year to $236 million. Revenues generated from Europe increased 0.6% to $185.4 million, while the metric in the Americas increased 2.4% to $323.2 million.
Nordson reports revenues under three segments. The segments are Industrial Precision Solutions, Medical and Fluid Solutions and Advanced Technology Solutions. A brief snapshot of the segmental sales is provided below:
Revenues from Industrial Precision Solutions amounted to $392.2 million, down 3.3% from the year-ago fiscal quarter’s level. The segment contributed 52.7% to NDSN’s top line in the quarter.
Organic sales decreased 5.5% from the year-ago fiscal quarter’s level. Acquisitions boosted sales by 1.2% while foreign currency translation had a positive impact of 1%.
Revenues from Medical and Fluid Solutions amounted to $200.2 million, up 18.7% from the year-ago fiscal quarter’s level. The segment contributed 26.9% to NDSN’s top line.
Organic sales decreased 3.2% from the year-ago fiscal quarter’s level. Acquisitions boosted sales by 21.4% while foreign currency translation had a positive impact of 0.5%.
Advanced Technology Solutions’ sales were $152.1 million, up 4.7% from the year-ago fiscal quarter’s figure. The metric represented 20.4% of Nordson’s revenues in the period.
Organic sales increased 3.9% from the year-ago fiscal quarter’s level. Foreign currency translation had a positive impact of 0.8%.
Margin Profile
Nordson’s cost of sales increased 1.9% from the year-ago fiscal quarter’s level to $341.7 million. Gross profit was $402.8 million, up 4.9% from the year-ago fiscal quarter’s level. The gross margin increased 70 basis points (bps) to 54.1%.
Selling and administrative expenses increased 12.5% year over year to $223.9 million. Adjusted EBITDA was $241.1 million, the margin being 32.4%. Operating income was $178.9 million, down 3.2% year on year. Operating margin of 24% decreased 170 bps from the year-ago period.
Net interest expenses totaled $27.3 million, reflecting a 5.4% increase from the year-ago fiscal quarter’s level.
Nordson’s Balance Sheet & Cash Flow
At the time of exiting fiscal 2024, Nordson’s cash and cash equivalents were $116 million, marginally higher than $115.7 million recorded at the end of fiscal 2023. Long-term debt was $2.1 billion compared with $1.6 billion recorded at the end of fourth-quarter fiscal 2023.
In fiscal 2024, NDSN generated net cash of $556.2 million from operating activities, down 13.2% from the last fiscal year period’s tally. Capital invested in purchasing property, plant and equipment totaled $64.4 million, up 86.1% from the year-ago fiscal period.
Dividends/Share Buyback
In fiscal 2024, Nordson paid out dividends of $161.4 million, up 7.3% from $150.4 million in the previous fiscal year.
Treasury purchase shares amounted to $33.3 million, down from $89.7 million in the last fiscal year.
NDSN’s Outlook
For fiscal 2025 (ending October 2025), Nordson anticipates adjusted earnings to be in the range of $9.70-$10.50 per share. Sales are expected to be in the range of $2,750-$2,870 million.
For the first quarter of fiscal 2025 (ending January 2025), it projects sales to be in the range of $615-$655 million, with adjusted earnings of $1.95-$2.15 per share.
Zacks Rank & Key Picks
Nordson currently carries a Zacks Rank #3 (Hold). Here are some better-ranked stocks from the same space:
GHM delivered a trailing four-quarter average earnings surprise of 101.9%. In the past 60 days, the Zacks Consensus Estimate for GHM’s fiscal 2025 earnings has increased 8.4%.
Applied Industrial Technologies (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). AIT delivered a trailing four-quarter average earnings surprise of 5%.
In the past 60 days, the consensus estimate for AIT’s 2024 earnings has inched up 0.7%.
RBC Bearings (RBC - Free Report) currently carries a Zacks Rank of 2. RBC delivered a trailing four-quarter average earnings surprise of 2.5%.
In the past 60 days, the consensus estimate for RBC Bearings’ fiscal 2025 (ending March 2025) earnings has increased 0.5%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Nordson's Q4 Earnings & Revenues Top Estimates, Increase Y/Y
Nordson Corporation’s (NDSN - Free Report) fourth-quarter fiscal 2024 (ended Sept. 30, 2024) adjusted earnings of $2.78 per share surpassed the Zacks Consensus Estimate of $2.59. The bottom line increased 2.6% year over year.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
Quarterly Results of NDSN
Nordson’s revenues were $744.5 million, up 4% from the year-ago fiscal quarter’s number, driven by solid momentum in the Medical and Fluid Solutions segment. Revenues beat the consensus estimate of $733 million.
Organic sales declined 3% year over year due to softness in the polymer processing and precision agriculture product lines. Acquisitions had a positive impact of 6% while foreign currency translation had a positive impact of 1%. Exiting the fiscal year, the company’s backlog totaled $580 million.
Nordson Corporation Price, Consensus and EPS Surprise
Nordson Corporation price-consensus-eps-surprise-chart | Nordson Corporation Quote
On a regional basis, revenues from the Asia Pacific region increased 7.5% year over year to $236 million. Revenues generated from Europe increased 0.6% to $185.4 million, while the metric in the Americas increased 2.4% to $323.2 million.
Nordson reports revenues under three segments. The segments are Industrial Precision Solutions, Medical and Fluid Solutions and Advanced Technology Solutions. A brief snapshot of the segmental sales is provided below:
Revenues from Industrial Precision Solutions amounted to $392.2 million, down 3.3% from the year-ago fiscal quarter’s level. The segment contributed 52.7% to NDSN’s top line in the quarter.
Organic sales decreased 5.5% from the year-ago fiscal quarter’s level. Acquisitions boosted sales by 1.2% while foreign currency translation had a positive impact of 1%.
Revenues from Medical and Fluid Solutions amounted to $200.2 million, up 18.7% from the year-ago fiscal quarter’s level. The segment contributed 26.9% to NDSN’s top line.
Organic sales decreased 3.2% from the year-ago fiscal quarter’s level. Acquisitions boosted sales by 21.4% while foreign currency translation had a positive impact of 0.5%.
Advanced Technology Solutions’ sales were $152.1 million, up 4.7% from the year-ago fiscal quarter’s figure. The metric represented 20.4% of Nordson’s revenues in the period.
Organic sales increased 3.9% from the year-ago fiscal quarter’s level. Foreign currency translation had a positive impact of 0.8%.
Margin Profile
Nordson’s cost of sales increased 1.9% from the year-ago fiscal quarter’s level to $341.7 million. Gross profit was $402.8 million, up 4.9% from the year-ago fiscal quarter’s level. The gross margin increased 70 basis points (bps) to 54.1%.
Selling and administrative expenses increased 12.5% year over year to $223.9 million. Adjusted EBITDA was $241.1 million, the margin being 32.4%. Operating income was $178.9 million, down 3.2% year on year. Operating margin of 24% decreased 170 bps from the year-ago period.
Net interest expenses totaled $27.3 million, reflecting a 5.4% increase from the year-ago fiscal quarter’s level.
Nordson’s Balance Sheet & Cash Flow
At the time of exiting fiscal 2024, Nordson’s cash and cash equivalents were $116 million, marginally higher than $115.7 million recorded at the end of fiscal 2023. Long-term debt was $2.1 billion compared with $1.6 billion recorded at the end of fourth-quarter fiscal 2023.
In fiscal 2024, NDSN generated net cash of $556.2 million from operating activities, down 13.2% from the last fiscal year period’s tally. Capital invested in purchasing property, plant and equipment totaled $64.4 million, up 86.1% from the year-ago fiscal period.
Dividends/Share Buyback
In fiscal 2024, Nordson paid out dividends of $161.4 million, up 7.3% from $150.4 million in the previous fiscal year.
Treasury purchase shares amounted to $33.3 million, down from $89.7 million in the last fiscal year.
NDSN’s Outlook
For fiscal 2025 (ending October 2025), Nordson anticipates adjusted earnings to be in the range of $9.70-$10.50 per share. Sales are expected to be in the range of $2,750-$2,870 million.
For the first quarter of fiscal 2025 (ending January 2025), it projects sales to be in the range of $615-$655 million, with adjusted earnings of $1.95-$2.15 per share.
Zacks Rank & Key Picks
Nordson currently carries a Zacks Rank #3 (Hold). Here are some better-ranked stocks from the same space:
Graham Corporation (GHM - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
GHM delivered a trailing four-quarter average earnings surprise of 101.9%. In the past 60 days, the Zacks Consensus Estimate for GHM’s fiscal 2025 earnings has increased 8.4%.
Applied Industrial Technologies (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). AIT delivered a trailing four-quarter average earnings surprise of 5%.
In the past 60 days, the consensus estimate for AIT’s 2024 earnings has inched up 0.7%.
RBC Bearings (RBC - Free Report) currently carries a Zacks Rank of 2. RBC delivered a trailing four-quarter average earnings surprise of 2.5%.
In the past 60 days, the consensus estimate for RBC Bearings’ fiscal 2025 (ending March 2025) earnings has increased 0.5%.